Compare DAC & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAC | GRDN |
|---|---|---|
| Founded | 1972 | 2004 |
| Country | Greece | United States |
| Employees | N/A | 3600 |
| Industry | Marine Transportation | Retail-Drug Stores and Proprietary Stores |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2006 | N/A |
| Metric | DAC | GRDN |
|---|---|---|
| Price | $116.30 | $37.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $112.50 | $40.25 |
| AVG Volume (30 Days) | 52.1K | ★ 563.6K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.04% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.63 |
| P/E Ratio | ★ $4.01 | $117.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $75.11 | $19.17 |
| 52 Week High | $118.90 | $41.36 |
| Indicator | DAC | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 55.49 | 50.79 |
| Support Level | $91.64 | $28.07 |
| Resistance Level | $117.86 | $37.78 |
| Average True Range (ATR) | 2.75 | 1.48 |
| MACD | 0.12 | -0.14 |
| Stochastic Oscillator | 66.45 | 40.32 |
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.